Enabling Innovative Drug Discovery with Advanced Technologies
Lead optimization stage of drug discovery is to maintain favorable properties in lead compounds while improving on deficiencies in the lead structure. The goal of lead optimization is to generate one or several preclinical candidates. Generally molecules need to be examined in efficacy and toxicity, PK/PD studies, metabolic profiling, chemical stability study, salt selection. HitGen provide services in medicinal chemistry, computational chemistry, AI based design, project DEL, compound scale-up, in vitro toxicity, in vitro pharmacology, in vivo pharmacology, pharmacokinetics, non-GLP toxicity.
HitGen Inc.
Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China
Tel : +86-28-8519-7385
HitGen Pharmaceuticals Inc.(US Subsidiary)
Tel : +1-(508)-840-9646
Vernalis (R&D) Limited (UK Subsidiary)
Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom
Tel : +44(0)1223-895555
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information